Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Serum Gamma Glutamyl Transferase Activity in Liver Diseases


Affiliations
1 Saveetha Dental College and Hospitals, Chennai, India
     

   Subscribe/Renew Journal


AIM: The aim is to review about serum gamma Glutamyl transferase level in liver diseases. BACKGROUND: Serum Gamma glutamyl transferase is a membrane bound glycoproteins enzyme,which catalysts the transfer of the gamma glutamyl moiety of glutathione to various peptide acceptor. Gamma glutamyl transferase is present in hepatocytes and biliary epithelial cells, renal tubules, pancreas and intestine. Normal level of gamma glutamyl transferase is 9 - 85 u/L .GGT activity is widely used as a highly sensitive biochemical marker in the majority of malignant and non malignant liver diseases. Elevated GGT level of more than 10 times is observed in alcoholism and 2.3 times greater in non-alcoholic fatty acid liver disease. Some drugs and conditions interfere with GGT levels. GGT levels can be increased by alcohol phenytoin (Dilantin), an anti-seizure medication, and phenobarbitol, an antiseizure medication and sedative, and decreased by clofibrate, an anticholesterol drug, and birth control pills. OBJECTIVE: The objective of the review is to address the role of serum gamma glutamyl transferase activity in liver diseases. REASON: Serum gamma Glutamyl transferase also used as a bio marker for various liver disease. So it's necessary for the medical professionals to take serum GGT into account for diagnosis of liver disease.

Keywords

Bacillus thuringiensis (Bt), Spore-Crystal Proteins, Vegetative Proteins. SDS-PAGE, Antioxidant.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Johanna Hietala, Heidi Koivisto, Petra Antilla, Onni Neimela, comparison of the combined marker GGT –CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers, 2006, Oxford journals, volume 41, issue 5, 528-533
  • Robert. S o’ Shea, Shrinivas dasarathy, authur .j., alcoholic liver disease, 2010, hepatology, volume 51, no 1.
  • Robert. S o’ Shea, shrinivas dasarathy, Aurthur j, alcoholic liver disease, 2010, hepatology, volume 51, no 1
  • Aronsen KF, Hanson A, Nosslin. B. The value of gamma glutamyl transpeptidase in differential viral hepatitis from obstructive jaundice. A statistical comparison with alkaline phosphatase. Actachirscand, July-August 1965, 130- 92-9, medline
  • Lum. G, Gambino SR.serum gamma glutamyl transpeptidase activity as an indicator of disease of liver, pancreas or none, clinchem.aprol 1972, 18(4): 358-62. medline
  • Ruttenburg AM, Goldbarg JA, Pineda EP, erum gamma glutamyl transpeptidase activity in hepatobiliary pancreatic disease. gastroenterlogy.1963.45-43
  • Cabrera-Abreu JC, green A, gamma glutamyl transferase, value of its measurements I. Paediatrics.ann clinbiochem, jan 202, 39 :22-5
  • Elemernemenskzy and John A. Lott, gamma glutamyl transferase and its isoenzymes: progress and problem, clinical chemistry, volume 31/6, 797-803(1985)
  • Elemernemenskzy and John A.lott, gamma glutamyl transferase and its isoenzymes: progress and problem, clinical chemistry, volume 31/6, 797-803(1985)
  • P.C Sharpe, R. Mcbride and G.P.R archbold, biochemical markers of alcoholic abuse, Q. J. Med 1996.137-144.
  • Whitefield, r.e. Founder, G. Neale and D. W. Moss, serum gamma glutamyl transpeptidase activity in liver disease, gut, 1972, 702-708
  • Whitefield, R.E. Founder, G. Neale and D.W, Moss, serum gamma glutamyl Transpeptidase activity in liver disease.gut, 1972, 13, 702-708
  • Whitefield, R. E. Founder, G. Neale and D.W. Moss, serum gamma glutamyl transpeptidase activity in liver disease, gut, 1972, 13, 702-708
  • Whitefield R.E founder, G. Neale and D. W. Moss, serum gamma glutamyl transpeptidase activity in liver disease.gut 1972, 13, 702-708

Abstract Views: 16

PDF Views: 0




  • Serum Gamma Glutamyl Transferase Activity in Liver Diseases

Abstract Views: 16  |  PDF Views: 0

Authors

J. H. Affrin
Saveetha Dental College and Hospitals, Chennai, India
G. Savitha
Saveetha Dental College and Hospitals, Chennai, India

Abstract


AIM: The aim is to review about serum gamma Glutamyl transferase level in liver diseases. BACKGROUND: Serum Gamma glutamyl transferase is a membrane bound glycoproteins enzyme,which catalysts the transfer of the gamma glutamyl moiety of glutathione to various peptide acceptor. Gamma glutamyl transferase is present in hepatocytes and biliary epithelial cells, renal tubules, pancreas and intestine. Normal level of gamma glutamyl transferase is 9 - 85 u/L .GGT activity is widely used as a highly sensitive biochemical marker in the majority of malignant and non malignant liver diseases. Elevated GGT level of more than 10 times is observed in alcoholism and 2.3 times greater in non-alcoholic fatty acid liver disease. Some drugs and conditions interfere with GGT levels. GGT levels can be increased by alcohol phenytoin (Dilantin), an anti-seizure medication, and phenobarbitol, an antiseizure medication and sedative, and decreased by clofibrate, an anticholesterol drug, and birth control pills. OBJECTIVE: The objective of the review is to address the role of serum gamma glutamyl transferase activity in liver diseases. REASON: Serum gamma Glutamyl transferase also used as a bio marker for various liver disease. So it's necessary for the medical professionals to take serum GGT into account for diagnosis of liver disease.

Keywords


Bacillus thuringiensis (Bt), Spore-Crystal Proteins, Vegetative Proteins. SDS-PAGE, Antioxidant.

References